JPS5359016A - Pharmatoceutical composition - Google Patents

Pharmatoceutical composition

Info

Publication number
JPS5359016A
JPS5359016A JP10099677A JP10099677A JPS5359016A JP S5359016 A JPS5359016 A JP S5359016A JP 10099677 A JP10099677 A JP 10099677A JP 10099677 A JP10099677 A JP 10099677A JP S5359016 A JPS5359016 A JP S5359016A
Authority
JP
Japan
Prior art keywords
pharmatoceutical
composition
pharmatoceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10099677A
Other languages
English (en)
Other versions
JPS646172B2 (ja
Inventor
Roger Withington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt and Colman Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt and Colman Products Ltd filed Critical Reckitt and Colman Products Ltd
Publication of JPS5359016A publication Critical patent/JPS5359016A/ja
Publication of JPS646172B2 publication Critical patent/JPS646172B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP10099677A 1976-11-09 1977-08-23 Pharmatoceutical composition Granted JPS5359016A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB46543/76A GB1524740A (en) 1976-11-09 1976-11-09 Pharmaceutical compositions for use in the suppression of gastric reflux

Publications (2)

Publication Number Publication Date
JPS5359016A true JPS5359016A (en) 1978-05-27
JPS646172B2 JPS646172B2 (ja) 1989-02-02

Family

ID=10441659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10099677A Granted JPS5359016A (en) 1976-11-09 1977-08-23 Pharmatoceutical composition

Country Status (15)

Country Link
US (1) US4140760A (ja)
JP (1) JPS5359016A (ja)
AU (1) AU509823B2 (ja)
BE (1) BE858003A (ja)
CA (1) CA1083964A (ja)
CY (1) CY1131A (ja)
DE (1) DE2738014A1 (ja)
FR (1) FR2369843A1 (ja)
GB (1) GB1524740A (ja)
HK (1) HK59681A (ja)
IE (1) IE45655B1 (ja)
KE (1) KE3175A (ja)
NL (1) NL188892C (ja)
NZ (1) NZ184931A (ja)
ZA (1) ZA774920B (ja)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0764737B2 (ja) * 1984-04-19 1995-07-12 ローヌ−プーラン ローラー インターナショナル （ホウルディングス） インコーポレイテッド 制酸組成物
JPH07103039B2 (ja) * 1986-03-07 1995-11-08 ローヌ―プーラン ローラー インターナショナル（ホウルディングス） インコーポレイテッド 粘度安定制酸性組成物の製造方法
JP2001522368A (ja) * 1997-04-30 2001-11-13 レキット アンド コールマン プロダクツ リミテッド 流動性アルギン酸塩組成物
JP2005513079A (ja) * 2001-12-20 2005-05-12 エヌ・ヴイ・ヌートリシア ソフトドリンク代替品
JP2009502897A (ja) * 2005-07-28 2009-01-29 レキット ベンキサー ヘルスケア （ユーケイ） リミテッド アルギネート及び／又はアルギン酸を含む粒状組成物
JP2013525313A (ja) * 2010-04-23 2013-06-20 エス−バイオテック ホールディング エーピーエス 胃酸を中和する固形医薬組成物
US9255517B2 (en) 2012-09-14 2016-02-09 Yanmar Co., Ltd. Engine device

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228231A1 (de) * 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung
GB8323624D0 (en) * 1983-09-02 1983-10-05 Reckitt & Colmann Prod Ltd Medicinal compositions
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
US4869902A (en) * 1984-04-19 1989-09-26 Rorer Pharmaceutical Corporation Antacid composition
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
EP0250572A1 (en) * 1986-01-03 1988-01-07 The University Of Melbourne Gastro-oesophageal reflux composition
US5254591A (en) * 1986-01-03 1993-10-19 The University Of Melbourne Pharmaceutical composition for treating gastroesophageal reflux
US5112813A (en) * 1986-03-07 1992-05-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Process for the preparation of a viscosity-stable antacid composition
US5002777A (en) * 1986-06-24 1991-03-26 Norcliff Thayer Inc. Encapsulated antacid
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
US5460803A (en) * 1989-05-24 1995-10-24 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US5827247A (en) * 1991-08-20 1998-10-27 Bioderm External incontinence device and vapor-absorptive adhesive compositions
US5360793A (en) * 1993-05-24 1994-11-01 Sterling Winthrop Inc. Rafting antacid formulation
US5427768A (en) * 1993-06-23 1995-06-27 American Dental Association Health Foundation Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use
US5455050A (en) * 1993-11-12 1995-10-03 Mcneil-Ppc, Inc. Aqueous antacids with calcium carbonate and magnesium salt
GB9504599D0 (en) * 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
US6099871A (en) * 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
GB9708772D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
CA2323212A1 (en) * 1998-03-11 1999-09-16 Smithkline Beecham Corporation Process of making an aqueous calcium carbonate suspension
US20030220258A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
GB9812426D0 (en) * 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB0005743D0 (en) * 2000-03-10 2000-05-03 Reckitt & Colmann Prod Ltd Pharmaceutical compositions including alginates
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
GB0012094D0 (en) * 2000-05-19 2000-07-12 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US20030165606A1 (en) * 2001-07-18 2003-09-04 Lasekan John B. Anti-regurgitation formula and uses thereof
SE0103613D0 (sv) * 2001-10-30 2001-10-30 Astrazeneca Ab Novel formulation
SE0103722D0 (sv) * 2001-10-30 2001-10-30 Astrazeneca Ab Novel formulation
US6779530B2 (en) * 2002-01-23 2004-08-24 Schweitzer-Mauduit International, Inc. Smoking articles with reduced ignition proclivity characteristics
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
TR200300510A2 (tr) * 2003-04-18 2004-11-22 Sanovel �La� Sanay� Ve T�Caret A.�. Dağılan alendronat mikropartikül formülasyonu
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
DE102004063612B4 (de) * 2004-01-02 2017-01-12 Manfred Helms Gelartiges Basenpräparat sowie Verwendung eines Gelbildners zu dessen Herstellung
US20060073202A1 (en) * 2004-10-05 2006-04-06 Rocca Jose G Dual component medicament delivery system
US8151806B2 (en) * 2005-02-07 2012-04-10 Schweitzer-Mauduit International, Inc. Smoking articles having reduced analyte levels and process for making same
SE530605C2 (sv) * 2005-09-29 2008-07-15 Barbara Nelson Läkemedel innehållande ett syrahämmande medel, avseende att användas för att motverka och bota luftvägssjukdomar
CN101631476B (zh) * 2005-10-05 2012-07-04 Fmc生物聚合物联合股份有限公司 胶凝组合物和方法
EP1864692A1 (en) * 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
EP2031990B1 (en) * 2006-06-01 2017-07-26 Schweitzer-Mauduit International, Inc. Free air burning smoking articles with reduced ignition proclivity characteristics
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20090148530A1 (en) 2007-12-08 2009-06-11 Jamie Koufman Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
WO2013111077A1 (en) 2012-01-27 2013-08-01 Institute Of Bioorganic Chemistry Pharmaceutical composition as a substance for antireflux antacid drug
ITRM20120041A1 (it) 2012-02-08 2013-08-09 Dicofarm Spa "prodotto a base di glucomannano e chitosano utile per il trattamento del reflusso gastroesofageo"
RU2479318C1 (ru) * 2012-03-29 2013-04-20 Общество с ограниченной ответственностью "ВИТТА" (ООО "ВИТТА") Способ получения лекарственных и биологически активных средств
KR101417287B1 (ko) * 2012-06-15 2014-07-08 동아제약 주식회사 신규한 위식도역류질환 치료용 조성물
IN2015DN01369A (ja) * 2012-07-19 2015-07-03 Relypsa Inc
KR102173454B1 (ko) 2012-10-11 2020-11-04 슈바이쳐-모뒤 인터내셔널, 인크. 감소된 발화 성향 특징을 갖는 래퍼
KR102303835B1 (ko) * 2014-01-08 2021-09-16 영진약품 주식회사 수성의 유동성 액체 조성물 및 이의 제조방법
ITUB20159732A1 (it) 2015-12-22 2017-06-22 S I I T S R L Servizio Int Imballaggi Termosaldanti Composizioni orali per il trattamento della malattia da reflusso gastroesofageo
FR3071728B1 (fr) 2017-09-29 2019-09-27 Laboratoires Arkopharma Composition adaptee pour former un radeau gastrique gelifie
IL277016B1 (en) * 2018-03-02 2024-09-01 Pharagen Llc Acid reflux treatment formulations that include sodium alginate
EP3797818B1 (en) 2018-05-23 2023-01-18 Shanghai WD Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
CN114191307A (zh) 2020-09-17 2022-03-18 上海汉都医药科技有限公司 一种口腔滞留装置及其制备方法
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
CN115777783A (zh) * 2022-07-04 2023-03-14 浙江上方生物科技有限公司 一种防止胃食管倒流的健康饮料及其制备方法
WO2024030933A1 (en) 2022-08-02 2024-02-08 Nutrition & Biosciences Usa 1, Llc Novel alginate and cellulose derivative based composition of the liquid anti-reflux formulation
WO2024030936A1 (en) * 2022-08-02 2024-02-08 Nutrition & Biosciences Usa 1, Llc Modified-release alginate-based composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5176415A (en) * 1974-12-26 1976-07-02 Riken Vitamin Oil Co Ltd Choyoseiseizaino seizohoho

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330729A (en) * 1963-10-04 1967-07-11 Goodrich Co B F Sustained release tablet containing medicament admixed in a waterinsoluble acrylic acid cross-linked polymer and selected basic magnesium or calcium diluent
US3326755A (en) * 1965-06-15 1967-06-20 Warner Lambert Pharmaceutical Alginate containing antacid compositions
US3767794A (en) * 1969-11-21 1973-10-23 Richardson Merrell Inc Antifoam preparations and method of preparing same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5176415A (en) * 1974-12-26 1976-07-02 Riken Vitamin Oil Co Ltd Choyoseiseizaino seizohoho

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0764737B2 (ja) * 1984-04-19 1995-07-12 ローヌ−プーラン ローラー インターナショナル （ホウルディングス） インコーポレイテッド 制酸組成物
JPH07103039B2 (ja) * 1986-03-07 1995-11-08 ローヌ―プーラン ローラー インターナショナル（ホウルディングス） インコーポレイテッド 粘度安定制酸性組成物の製造方法
JP2001522368A (ja) * 1997-04-30 2001-11-13 レキット アンド コールマン プロダクツ リミテッド 流動性アルギン酸塩組成物
JP2005513079A (ja) * 2001-12-20 2005-05-12 エヌ・ヴイ・ヌートリシア ソフトドリンク代替品
JP2005513077A (ja) * 2001-12-20 2005-05-12 エヌ・ヴイ・ヌートリシア ペクチンを含有するマトリックス形成組成物
JP2009502897A (ja) * 2005-07-28 2009-01-29 レキット ベンキサー ヘルスケア （ユーケイ） リミテッド アルギネート及び／又はアルギン酸を含む粒状組成物
JP2013525313A (ja) * 2010-04-23 2013-06-20 エス−バイオテック ホールディング エーピーエス 胃酸を中和する固形医薬組成物
JP2016166220A (ja) * 2010-04-23 2016-09-15 エス−バイオテック ホールディング エーピーエス 胃酸を中和する固形医薬組成物
US9255517B2 (en) 2012-09-14 2016-02-09 Yanmar Co., Ltd. Engine device

Also Published As

Publication number Publication date
FR2369843B1 (ja) 1980-12-26
ZA774920B (en) 1979-03-28
AU2830677A (en) 1979-03-08
HK59681A (en) 1981-12-11
IE45655B1 (en) 1982-10-20
NZ184931A (en) 1979-06-08
CA1083964A (en) 1980-08-19
NL188892C (nl) 1992-11-02
KE3175A (en) 1982-01-08
NL7709307A (nl) 1978-05-11
IE45655L (en) 1978-05-09
DE2738014C2 (ja) 1988-08-18
AU509823B2 (en) 1980-05-29
JPS646172B2 (ja) 1989-02-02
GB1524740A (en) 1978-09-13
CY1131A (en) 1982-05-07
DE2738014A1 (de) 1978-05-18
BE858003A (fr) 1977-12-16
US4140760A (en) 1979-02-20
FR2369843A1 (fr) 1978-06-02

Similar Documents

Publication Publication Date Title
JPS5359016A (en) Pharmatoceutical composition
JPS5326331A (en) Decayeddtooth preventing composition
JPS5285123A (en) Fluorocarbonsiloxane compositions
JPS5316787A (en) Specificcreactive composition
JPS52140700A (en) Covering composition
AU2732277A (en) Soil-hardening composition
JPS5356325A (en) Composition having antiicoagulation effect
JPS5355360A (en) Heattactivating composition
JPS5488958A (en) Cumyuphenol derivative composition
JPS52128946A (en) Compositions
JPS52143827A (en) Improved lighttsensitive composition
JPS52117437A (en) Antiicoccidium composition
JPS5371075A (en) Compositions
ZA773013B (en) Anti-odorant compositions
GB1547106A (en) Grightening compositions
IL51365A0 (en) Coccidiocidal composition
JPS5341436A (en) Antiiparasite composition
JPS52142752A (en) Moistureeresistant composition
GB1551637A (en) Hygieniccosmetic compositions
IE44735L (en) Fibrinogenase composition
JPS5299226A (en) Novel antiihypertension composition
JPS5299227A (en) Novel antiihypertension composition
GB1552517A (en) Colour-former compositions
JPS52103201A (en) Photoosensitive composition
JPS5299225A (en) Novel antiihypertension composition